Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  10/18/2011
 
Trade Name:  Ixempra Kit
 
Generic Name or Proper Name (*):  ixabepilone
 
Indications Studied:  Advanced or refractory solid tumors
 
Label Changes Summary:  The effectiveness in pediatric patients has not been established Ixempra was evaluated in one Phase 1 and one Phase 2 trial Adverse reactions were similar to adults, and no new safety signals were identified
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Bristol-Myers Squibb
 
Pediatric Exclusivity Granted Date:  04/05/2011
 
NNPS:  FALSE'
 
Therapeutic Category:  Antineoplastic
 
-
-